By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Mar 1, 2020/CPG
This guideline offers recommendations for the diagnosis and management of subacromial pain syndrome (or shoulder impingement syndrome).
Jun 22, 2022/CPG
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple sclerosis. [Formerly NICE CG186.]
Oct 19, 2014/Test & Measure
Measures endurance by assessing walking distance.
Jan 14, 2025/CPG
This guideline, from the United Kingdom's National Institute for Health and Care Excellence (NICE), covers the prevention and management of overweight, obesity, and central adiposity in children, young people, and adults. It brings together and updates all NICE's previous guidelines on overweight and
Jun 1, 2020/CPG
This guideline describes the critical decision points in the management of Dyslipidemia (LIPIDS) and provides clear and comprehensive evidence based recommendations.
Oct 19, 2021/News
There are many similarities, but WHO's recent clinical case definition includes elements that are worth noting by PTs and payers.
May 25, 2023/CPG
This guideline from the American College of Rheumatology outlines initial recommendations on the management of rheumatoid arthritis with exercise, rehabilitation, diet, and additional integrative interventions.
Dec 7, 2023/CPG
This guideline provides evidence-based recommendations on nonsurgical interventions for chronic primary low back pain (CPLBP) in adults, including older people, that can be delivered in primary and community care settings to improve CPLBP-related health and well-being outcomes.
Nov 11, 2021/CPG
This "living" guideline covers identifying, assessing, and managing the long-term effects of COVID-19, frequently described as "long COVID." It makes recommendations about care in all health care settings for adults, children, and young people who have new or ongoing symptoms lasting four weeks or more
Dec 2, 2025/CPG